Therapeutic areas
Our therapeutic
expertise
Our experience in managing complex hospital-based studies spans multiple therapeutic areas and specific indications across Phase I-III studies, with a core therapeutic focus on Oncology and Rare Disease.
Our combined experience in clinical pharmacology and clinical development also includes CNS, respiratory, anti-Infectives and vaccines, dermatology, gastro-Intestinal, critical care medicine, medical devices, hepatic and biliary, and pulmonary.
It is this wide therapeutic experience working in various indications which enables us to bring insight to your clinical development and manage the most challenging studies.
Extensive therapeutic expertise
We offer expertise across a broad range of therapeutic areas in clinical research, enabling efficient development from beginning to end. With specialist knowledge and experience in multiple areas, we ensure your drug development process transitions seamlessly across all therapeutic specialties.
Whether your project requires a full development programme or specialist service, we help get your drug to market faster.
CNS Clinical Trials
Using a variety of neuroscience tools and techniques at the Phase I or first-in-human (FIH) phase of the drug development pipeline, it is now possible to gather the data and insights needed to build a detailed picture of the CNS effects of drug candidates which can help to build a business case for future CNS clinical trials.
This means that the development of your therapeutic for a CNS indication requires access to specialist support from your Contract Research Organisation
